Vertex Pharmaceuticals Incorporated Stock Forecast
Stock Analysis |
|
Risk Assessment |
|
Trading Strategy |
|
Green day on Thursday for Vertex Pharmaceuticals Incorporated
(Updated on Sep 12, 2024)
The Vertex Pharmaceuticals Incorporated stock price gained 0.82% on the last trading day (Thursday, 12th Sep 2024), rising from $474.74 to $478.65. During the last trading day the stock fluctuated 2.36% from a day low at $468.46 to a day high of $479.51. The price has risen in 6 of the last 10 days but is still down by -2.26% for this period. Volume fell on the last day by -206 thousand shares and in total, 736 thousand shares were bought and sold for approximately $352.13 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock is moving within a horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Vertex Pharmaceuticals Incorporated stock with a 90% probability to be traded between $465.60 and $507.04 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stock seldom manage to go directly from the bottom of a trend up to the top. Stock turning up in the middle of a horizontal trend are therefore considered to be potential runners.
Have specific questions? Chat with our AI Analyst now!
VRTX Signals & Forecast
There are mixed signals in the stock today. The Vertex Pharmaceuticals Incorporated stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $481.12. On a fall, the stock will find some support from the short-term average at $472.92. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). A buy signal was issued from a pivot bottom point on Friday, September 06, 2024, and so far it has risen 2.28%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.
Support, Risk & Stop-loss for Vertex Pharmaceuticals Incorporated stock
Vertex Pharmaceuticals Incorporated finds support from accumulated volume at $476.91 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $11.05 between high and low, or 2.36%. For the last week the stock has had daily average volatility of 2.03%.
Our recommended stop-loss: $454.84 (-4.97%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 8 days ago.)
Trading Expectations (VRTX) For The Upcoming Trading Day Of Friday 13th
For the upcoming trading day on Friday, 13th we expect Vertex Pharmaceuticals Incorporated to open at $475.54, and during the day (based on 14 day Average True Range), to move between $468.56 and $488.74, which gives a possible trading interval of +/-$10.09 (+/-2.11%) up or down from last closing price. If Vertex Pharmaceuticals Incorporated takes out the full calculated possible swing range there will be an estimated 4.22% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $476.91 (0.36%) than the resistance at $491.57 (2.70%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Vertex Pharmaceuticals Incorporated stock A Buy?
Vertex Pharmaceuticals Incorporated holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
Current score: -0.705 Hold/Accumulate Unchanged
Predicted Opening Price for Vertex Pharmaceuticals Incorporated of Friday, September 13, 2024
Fair opening price September 13, 2024 | Current price |
---|---|
$475.54 ( 0.650%) | $478.65 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for VRTX
Fibonacci Support & Resistance Levels
Level | Price | |
---|---|---|
R3 | 486.59 | 1.66% |
R2 | 482.37 | 0.777% |
R1 | 479.76 | 0.232% |
Price | 478.65 | |
S1 | 471.32 | -1.53% |
S2 | 468.71 | -2.08% |
S3 | 464.49 | -2.96% |
Accumulated Volume Support & Resistance Levels
Level | Price | |
---|---|---|
R3 | 505.78 | 5.67% |
R2 | 495.89 | 3.60% |
R1 | 491.57 | 2.70% |
Price | 478.65 | |
S1 | 476.91 | -0.364% |
S2 | 468.72 | -2.07% |
S3 | 468.71 | -2.08% |
FAQ
Click here for our free guide on how to buy Vertex Pharmaceuticals Incorporated Stock.